Older patients with #cvCAD for whom #PCI was deferred until after TAVI had similar outcomes as those for whom it was not deferred, according to findings from the PRO-TAVI study presented in a Late-Breaking Clinical Trial session at #ACC26.
Learn more: https://bit.ly/4sFz75F
🚨 Key Findings From #ACC26 ALL-RISE
FFRangio, a minimally invasive, AI-assisted, novel method of measuring fractional flow reserve (FFR), performed similarly to traditional wire-based testing in patients with #cvCAD undergoing assessment for #PCI.
More: https://bit.ly/4s3mGPZ #CardioSky
GPS-CAD is the largest global study of race, ethnicity, and environment in ACAD, spanning 6 continents. It is the first to examine how country and race/ethnicity shape atherosclerosis vs traditional risk factors to inform local strategies. https://bit.ly/4uT0aMp #JACCAsia #ACC26 #cvCAD #CardioSky
Stress CMR-guided #cvImaging in patients w/ chest pain & nonobstructive #cvCAD was superior to angiography only in correctly diagnosing microvascular angina & improving chest pain symptoms & QoL, based on findings from CorCMR trial presented at #AHA25. 🔗 https://bit.ly/4hRZ0dJ
Four key plasma proteins associated w/ potential causal roles in blood pressure regulation and increased risk of cardiovascular events, including #cvCAD and stroke, were identified in a Mendelian randomization study.
Read the journal scan for more ➡️ https://bit.ly/435QUZ3
In patients with de novo coronary artery disease, #DCB angioplasty with rescue stenting was associated with a higher rate of Device-oriented Composite Endpoint compared to intended DES implantation regarding DoCE at 3 years. https://bit.ly/4nePRNp
#TCT2025 #JACC #cvCAD #CardioSky
FFR-guided #PCI using zotarolimus DES provides significantly better long-term value than CABG for treatment of patients with multivessel CAD, with equivalent clinical outcomes at substantially lower cost. https://bit.ly/47vJgJS
#TCT2025 #JACC #cvCABG #cvCAD #CardioSky
🏆 Congratulations to the #ACCMidEast abstract competition winners! Their research explores:
📊 Non-HDL-C levels in Middle Eastern #ASCVD patients
🫀 LVMI impact on RV impairment
🔬Comparative efficacy of imaging agents in detecting #cvCAD
🔗 https://bit.ly/3WnSt0v
#ACCIntl
Noninferiority was not demonstrated in the OPTION-STEMI trial comparing immediate complete revascularization with staged complete revascularization in patients with #STEMI and multivessel CAD. Read more: https://bit.ly/47QKKyX
#ESCCongress #cvCAD
Coronary Artery Calcium #CAC #YesCCT Staging to Guide Preventive Interventions
#PowerOfZero #aspirin #statin #CardioSky #MedSky
#JACCAdvances #cvCAD
@jaccjournals.bsky.social @accintouch.bsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social
www.jacc.org/doi/10.1016/...
